National Institute of Hygiene and Epidemiology, Hanoi, Viet Nam.
Centers for Disease Control and Prevention, Atlanta, GA, USA.
BMC Infect Dis. 2024 Oct 18;24(1):1179. doi: 10.1186/s12879-024-10065-0.
Streptococcus pneumoniae (S. pneumoniae), Haemophilus influenzae (H. influenzae), and Neisseria meningitidis (N. meningitidis) are leading causes of childhood bacterial meningitis and preventable by vaccines. The aim of this hospital-based sentinel surveillance is to describe the epidemiological characteristics of pneumococcal meningitis, including disease burden, and to provide baseline data on pneumococcal serotype distribution to support decision making for pneumococcal conjugate vaccine (PCV) introduction in Vietnam.
Surveillance for probable bacterial meningitis in children 1-59 months of age is conducted in three tertiary level pediatric hospitals: one in Hanoi and two in Ho Chi Minh City. Cerebrospinal fluid (CSF) specimens were collected via lumbar puncture from children with suspected meningitis. Specimens were transferred immediately to the laboratory department of the respective hospital for cytology, biochemistry, and microbiology testing, including culture. PCR testing was conducted on CSF specimens for bacterial detection (S. pneumoniae, H. influenzae, and N. meningitidis) and pneumococcal serotyping.
During 2015-2018, a total of 1,803 children with probable bacterial meningitis were detected; 1,780 had CSF specimens available for testing. Of 245 laboratory-confirmed positive cases, the majority were caused by S. pneumoniae (229,93.5%). Of those with S. pneumoniae detected, over 70% were caused by serotypes included in currently available PCV products; serotypes 6 A/6B (27.1%), 14 (19.7%), and 23 F (16.2%) were the most common serotypes. Children with laboratory-confirmed pneumococcal meningitis were more likely to live in Hanoi (p < 0.0001) and children 12-23 months of age were at greater odds (OR = 1.65, 95% CI: 1.11, 2.43; p = 0.006) of having confirmed pneumococcal meningitis compared to children < 12 months of age when compared to those without laboratory-confirmed bacterial meningitis. Additionally, children with confirmed pneumococcal meningitis were more likely to exhibit signs and symptoms consistent with clinical meningitis compared to negative laboratory-confirmed meningitis cases (p < 0.0001) and had a greater odds of death (OR = 6.18, 95% CI: 2.98, 12.86; p < 0.0001).
Pneumococcal meningitis contributes to a large burden of bacterial meningitis in Vietnamese children. A large proportion are caused by serotypes covered by PCVs currently available. Introduction of PCV into the routine immunization program could reduce the burden of pneumococcal meningitis in Viet Nam.
肺炎链球菌(S. pneumoniae)、流感嗜血杆菌(H. influenzae)和脑膜炎奈瑟菌(N. meningitidis)是导致儿童细菌性脑膜炎的主要原因,可以通过疫苗预防。本基于医院的哨点监测旨在描述肺炎球菌性脑膜炎的流行病学特征,包括疾病负担,并提供肺炎球菌血清型分布的基线数据,以支持越南引入肺炎球菌结合疫苗(PCV)的决策。
对三家三级儿科医院(河内一家,胡志明市两家)1-59 个月龄疑似细菌性脑膜炎的儿童进行监测。对疑似脑膜炎的儿童进行腰椎穿刺采集脑脊液(CSF)标本。标本立即转移到各自医院的实验室部门进行细胞学、生物化学和微生物学检测,包括培养。对 CSF 标本进行 PCR 检测以检测细菌(S. pneumoniae、H. influenzae 和 N. meningitidis)和肺炎球菌血清分型。
2015-2018 年,共检测到 1803 例疑似细菌性脑膜炎儿童,其中 1780 例有可用的 CSF 标本进行检测。在 245 例实验室确诊阳性病例中,大多数由 S. pneumoniae 引起(229 例,93.5%)。在检测到的肺炎球菌中,超过 70%是由目前可用的 PCV 产品中包含的血清型引起的;血清型 6A/6B(27.1%)、14(19.7%)和 23F(16.2%)是最常见的血清型。与未确诊的细菌性脑膜炎儿童相比,实验室确诊的肺炎球菌性脑膜炎儿童更有可能居住在河内(p<0.0001),12-23 个月龄的儿童患实验室确诊的肺炎球菌性脑膜炎的几率更高(OR=1.65,95%CI:1.11,2.43;p=0.006)。此外,与实验室阴性的脑膜炎病例相比,实验室确诊的肺炎球菌性脑膜炎儿童更有可能出现符合临床脑膜炎的体征和症状(p<0.0001),且死亡风险更高(OR=6.18,95%CI:2.98,12.86;p<0.0001)。
肺炎球菌性脑膜炎在越南儿童细菌性脑膜炎中占很大比例。很大一部分是由目前可用的 PCV 覆盖的血清型引起的。将 PCV 纳入常规免疫规划可降低越南肺炎球菌性脑膜炎的负担。